CA2493483C - Endiandric acid h as c-maf inhibitors derivatives for use against asthma - Google Patents
Endiandric acid h as c-maf inhibitors derivatives for use against asthma Download PDFInfo
- Publication number
- CA2493483C CA2493483C CA2493483A CA2493483A CA2493483C CA 2493483 C CA2493483 C CA 2493483C CA 2493483 A CA2493483 A CA 2493483A CA 2493483 A CA2493483 A CA 2493483A CA 2493483 C CA2493483 C CA 2493483C
- Authority
- CA
- Canada
- Prior art keywords
- compound
- formula
- alkyl
- alkenyl
- branched
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Pulmonology (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Medicines Containing Plant Substances (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10235624A DE10235624A1 (de) | 2002-08-02 | 2002-08-02 | Endiandric acid H und ihre Derivate, Verfahren zu ihrer Herstellung und Verwendung derselben |
| DE10235624.6 | 2002-08-02 | ||
| PCT/EP2003/007821 WO2004014888A1 (de) | 2002-08-02 | 2003-07-18 | Endiandric acid h derivate als c-maf inhibitoren zur verwendung gegen asthma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2493483A1 CA2493483A1 (en) | 2004-02-19 |
| CA2493483C true CA2493483C (en) | 2011-09-20 |
Family
ID=30469404
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2493483A Expired - Fee Related CA2493483C (en) | 2002-08-02 | 2003-07-18 | Endiandric acid h as c-maf inhibitors derivatives for use against asthma |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7019028B2 (https=) |
| EP (1) | EP1529040B1 (https=) |
| JP (1) | JP4598523B2 (https=) |
| AT (1) | ATE314359T1 (https=) |
| AU (1) | AU2003250099B2 (https=) |
| BR (1) | BR0313199A (https=) |
| CA (1) | CA2493483C (https=) |
| DE (2) | DE10235624A1 (https=) |
| DK (1) | DK1529040T3 (https=) |
| ES (1) | ES2254980T3 (https=) |
| IL (1) | IL166439A (https=) |
| MX (1) | MXPA05000387A (https=) |
| WO (1) | WO2004014888A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1944361A1 (en) | 2007-01-11 | 2008-07-16 | INSERM (Institut National de la Santé et de la Recherche Médicale) | A method for expanding monocytes |
| CN108192972B (zh) | 2010-10-06 | 2022-09-09 | 生物医学研究机构基金会 | 用于乳腺癌转移的诊断、预后和治疗的方法 |
| EP2650682A1 (en) | 2012-04-09 | 2013-10-16 | Fundació Privada Institut de Recerca Biomèdica | Method for the prognosis and treatment of cancer metastasis |
| BR112014030750A2 (pt) | 2012-06-06 | 2017-08-22 | Inst Catalana Recerca Estudis Avancats | Método para diagnóstico, prognóstico e tratamento da metástase do câncer pulmonar |
| US10119171B2 (en) | 2012-10-12 | 2018-11-06 | Inbiomotion S.L. | Method for the diagnosis, prognosis and treatment of prostate cancer metastasis |
| ES2906586T3 (es) | 2012-10-12 | 2022-04-19 | Inbiomotion Sl | Método para el diagnóstico, pronóstico y tratamiento de metástasis de cáncer de próstata |
| WO2015019125A1 (en) * | 2013-08-05 | 2015-02-12 | Societe De Developpement Et De Recherche Industrielle | Molecular targets for the treatment of wounds, in particular chronic wounds |
| US11596642B2 (en) | 2016-05-25 | 2023-03-07 | Inbiomotion S.L. | Therapeutic treatment of breast cancer based on c-MAF status |
| KR20200104298A (ko) | 2017-11-22 | 2020-09-03 | 인바이오모션 에스.엘. | c-MAF 상태에 기반한 유방암의 요법 치료 |
-
2002
- 2002-08-02 DE DE10235624A patent/DE10235624A1/de not_active Withdrawn
-
2003
- 2003-07-18 MX MXPA05000387A patent/MXPA05000387A/es active IP Right Grant
- 2003-07-18 EP EP03784025A patent/EP1529040B1/de not_active Expired - Lifetime
- 2003-07-18 DE DE50302084T patent/DE50302084D1/de not_active Expired - Lifetime
- 2003-07-18 WO PCT/EP2003/007821 patent/WO2004014888A1/de not_active Ceased
- 2003-07-18 ES ES03784025T patent/ES2254980T3/es not_active Expired - Lifetime
- 2003-07-18 AT AT03784025T patent/ATE314359T1/de active
- 2003-07-18 AU AU2003250099A patent/AU2003250099B2/en not_active Ceased
- 2003-07-18 CA CA2493483A patent/CA2493483C/en not_active Expired - Fee Related
- 2003-07-18 DK DK03784025T patent/DK1529040T3/da active
- 2003-07-18 JP JP2004526742A patent/JP4598523B2/ja not_active Expired - Fee Related
- 2003-07-18 BR BR0313199-8A patent/BR0313199A/pt not_active Application Discontinuation
- 2003-07-25 US US10/627,850 patent/US7019028B2/en not_active Expired - Fee Related
-
2005
- 2005-01-23 IL IL166439A patent/IL166439A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| BR0313199A (pt) | 2005-06-21 |
| IL166439A (en) | 2009-12-24 |
| MXPA05000387A (es) | 2005-03-23 |
| IL166439A0 (en) | 2006-01-15 |
| US7019028B2 (en) | 2006-03-28 |
| DE50302084D1 (de) | 2006-02-02 |
| EP1529040B1 (de) | 2005-12-28 |
| AU2003250099B2 (en) | 2008-12-18 |
| DE10235624A1 (de) | 2004-02-19 |
| JP2006503006A (ja) | 2006-01-26 |
| ES2254980T3 (es) | 2006-06-16 |
| ATE314359T1 (de) | 2006-01-15 |
| DK1529040T3 (da) | 2006-05-08 |
| CA2493483A1 (en) | 2004-02-19 |
| US20040138313A1 (en) | 2004-07-15 |
| AU2003250099A1 (en) | 2004-02-25 |
| JP4598523B2 (ja) | 2010-12-15 |
| EP1529040A1 (de) | 2005-05-11 |
| WO2004014888A1 (de) | 2004-02-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU617139B2 (en) | New phenylethanolamines | |
| CA2493483C (en) | Endiandric acid h as c-maf inhibitors derivatives for use against asthma | |
| US4263463A (en) | Acetylenic secondary alcohols | |
| WO2019237645A1 (zh) | 一种高活性的独脚金内酯衍生物及其制备与应用 | |
| US4118505A (en) | Novel cyclopropanecarboxylates | |
| CN108840871B (zh) | 具有抗肿瘤活性的13-羟基金雀花碱肉桂酸酯类化合物及其制备方法 | |
| Ibi et al. | Syntheses and biological activities of tetramic acid and tetronic acid derivatives | |
| US4443619A (en) | Chlorocitric acids | |
| CN105994314A (zh) | 骆驼宁碱a在防治蚜虫中的应用 | |
| Chiji et al. | Two phenolic amides in the seed balls of sugar beet (Beta vulgaris L. var. saccharifera Alefeld) | |
| JP4077723B2 (ja) | クライネチンおよびその誘導体、調製方法および使用 | |
| JP5170608B2 (ja) | アフラトキシン生産阻害剤、及びそれを用いたアフラトキシン汚染防除方法 | |
| CN111777588B (zh) | 假臭草苯丙素类化合物及其应用 | |
| CN118978453A (zh) | 根皮素衍生物及其制备方法和应用 | |
| Shinta et al. | Synthesis of Piperine Amide Derivatives and Evaluation of Their Anti-inflammatory Activity | |
| 駒井功一郎 et al. | Plant Growth Inhibitors in Catchweed Seeds and Their Allelopathy. | |
| Solanki et al. | Eco-friendly synthesis and potent antifungal activity of 2-substituted coumaran-3-ones | |
| CN1499976A (zh) | 卡洛孢苷衍生物、其制备方法与应用 | |
| US4354039A (en) | Chlorocitric acids | |
| CN108101919B (zh) | 一种卤代二氢吡喃并吡咯酮化合物及其晶型和制备方法 | |
| IL159561A (en) | Eurotinones and derivatives thereof, processes for preparing them and their use | |
| CN121181624A (zh) | 一种新型生物碱类化合物Oreonudine G及其制备方法和应用 | |
| KR20130034458A (ko) | 벼 지상부 추출물, 벼 지상부 분획물, 이로부터 분리된 리그난 글리코시드 화합물 또는 이의 약학적으로 허용가능한 염을 유효성분으로 함유하는 염증성 질환의 예방 및 치료용 약학적 조성물 | |
| Pandey et al. | SYNTHESIS OF BIOLOGICALLY ACTIVE 1-(ARYLIDENE-AMINO-ETHYL)-2-METHYL/PHENYL-4-(BENZYLIDENE)-IMIDAZOLIN-5-ONES | |
| EP1150967A1 (en) | Therapeutic compounds and methods |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |
Effective date: 20130718 |